Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay

Table 1 Studies providing P. falciparum isolates for HRP-2 IC ₅₀ drug assays

Study	Years of enrolment	Location	Relevant inclusion criteria
Study	Years of enrolment	Province, Country	Relevant inclusion criteria
1	2005-07	Trat, Thailand¹	> 19 years old, any asexual P. falciparum parasitaemia
2	2006-07	Trat, Thailand¹	5-70 years old, any asexual P. falciparum parasitaemia
3	2006-07	Western Cambodia²:	18-65 years old, asexual P. falciparum parasitaemia, > 100 and < 100,000/μL
3	2006-07	Battambang
4	2008-09	Western Cambodia²:	18-65 years old, asexual P. falciparum parasitaemia, > 1000 and < 200,000/μL
4	2008-09	Battambang
5	2009-10	Western Cambodia²:	≥ 13 years old, any asexual P. falciparum parasitaemia
		Battambang, Pailin
		Northern Cambodia³:
		Oddar Mean Chey
		Preah Vihear
6	2010-11	Northern Cambodia³:	18-65 years old, any asexual P. falciparum parasitaemia
		Oddar Mean Chey
		Preah Vihear

¹ Thailand Ministry of Public Health Clinics in Borai, Khaosaming and Muang districts.
² Western Cambodia: Pailin (Pailin Hospital) and Battambang Provinces (Tasanh, Samlot, Chanlong Kuoy and Kampong Lpov health centers);
³ Northern Cambodia: Oddar Mean Chey (Anlong Veng, Trapang Tav, Trapang Prey, Trapang Prasat and Sraem health centers), and Preah Vihear Provinces.

ISSN: 1475-2875